Bridion 100 mg/mL Injection
PDF Leaflet Revision Date: 24 November 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Routine and immediate reversal of neuromuscular blockade induced by rocuronium or vecuronium.
Dosage (summary)
4 mg/kg for profound blockade, 2 mg/kg for shallow blockade, 16 mg/kg for immediate reversal.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
- Obese patients
- Paediatric patients
Pregnancy & Breastfeeding
Safety in pregnancy not established; caution in breastfeeding due to potential excretion in milk.
Key Drug Interactions
- Toremifene
- Fusidic acid
- Hormonal contraceptives
Contraindications
- Hypersensitivity to sugammadex or inactive ingredients
Common side effects
- Cough
- Airway complications
- Anaesthesia complications
- Procedural hypotension
Counselling Points
- Administer under anaesthetist supervision
- Monitor respiratory function post-reversal
- Inform about potential hypersensitivity reactions
Serious warnings
- Not for reversal of depolarising neuromuscular blocking agents
- Risk of bradycardia
- Monitor for recurrence of neuromuscular blockade
Important Disclaimer
The Bridion 100 mg/mL Injection professional information leaflet below is the property of Msd and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
